USPTO serial 77307534
MAP PHARMACEUTICALS, INC.
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- BENMAMAN, ALICE
- Law office
- DIVISIONAL UNIT
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with MAP PHARMACEUTICALS, INC.?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Diane M. Lambillotte
Diane M. Lambillotte Arnold & Porter LLP777 South Figueroa Street44th FloorLos Angeles, CA 90017Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical products for use in the treatment of cardiovascular diseases and disorders, urological diseases and disorders, gastrointestinal diseases and disorders, musculoskeletal diseases and disorders, hypertension, inflammation and inflammatory diseases and disorders, metabolic diseases and disorders, infectious diseases and disorders, immunological, bacterial, viral and fungal diseases and disorders, psychiatric diseases and disorders, allergies, diabetes, obesity, stroke, erectile and sexual dysfunction, and hemolytic diseases and disorders; pharmaceutical preparations, namely, cholesterol preparations, osteoporosis preparations, oncological preparations, dermatological preparations, ophthalmologic preparations, smoking cessation preparations, tissue and skin repair preparations and gynecological preparations; drug delivery devices, namely, inhalers containing pre-filled drug cartridges which deliver medication in liquid form via the pulmonary route, either directly to the lungs or for absorption and delivery in systemic circulation for use in the treatment of cardiovascular diseases and disorders, urological diseases and disorders, gastrointestinal diseases and disorders, musculoskeletal diseases and disorders, hypertension, inflammation and inflammatory diseases and disorders, metabolic diseases and disorders, infectious diseases and disorders, immunological, bacterial, viral and fungal diseases and disorders, psychiatric diseases and disorders, allergies, diabetes, obesity, stroke, erectile and sexual dysfunction, and hemolytic diseases and disorders; drug delivery devices, namely, inhalers containing pre-filled drug cartridges which deliver medication in liquid form via the pulmonary route, either directly to the lungs or for absorption and delivery in systemic circulation for use in the delivery of cholesterol preparations, osteoporosis preparations, oncological preparations, dermatological preparations, ophthalmologic preparations, smoking cessation preparations, tissue and skin repair preparations and gynecological preparations | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 28, 2014 | MAB6 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Aug 28, 2014 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Nov 28, 2011 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 28, 2011 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Sep 14, 2010 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED | — |
| Sep 11, 2010 | EX5G | SOU EXTENSION 5 GRANTED | — |
| Sep 1, 2010 | EXT5 | SOU EXTENSION 5 FILED | — |
| Sep 1, 2010 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Apr 29, 2010 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED | — |
| Apr 28, 2010 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Apr 23, 2010 | EXT4 | SOU EXTENSION 4 FILED | — |
| Apr 23, 2010 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Nov 9, 2009 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Nov 6, 2009 | EXT3 | SOU EXTENSION 3 FILED | — |
| Nov 6, 2009 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| May 26, 2009 | EX2G | SOU EXTENSION 2 GRANTED | — |
| May 19, 2009 | EXT2 | SOU EXTENSION 2 FILED | — |
| May 19, 2009 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Dec 12, 2008 | DPCC | DIVISIONAL PROCESSING COMPLETE | — |
| Dec 12, 2008 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Nov 17, 2008 | DRRR | DIVISIONAL REQUEST RECEIVED | — |
| Nov 17, 2008 | PAPER RECEIVED | — | |
| Nov 17, 2008 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Nov 17, 2008 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Nov 13, 2008 | EXT1 | SOU EXTENSION 1 FILED | — |
| Nov 13, 2008 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Nov 13, 2008 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Jun 3, 2008 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Mar 11, 2008 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Feb 20, 2008 | NPUB | NOTICE OF PUBLICATION | — |
| Feb 1, 2008 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jan 31, 2008 | CNEA | EXAMINER'S AMENDMENT MAILED | — |
| Jan 30, 2008 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 30, 2008 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jan 30, 2008 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jan 29, 2008 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 26, 2007 | AMPX | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED | — |
| Dec 26, 2007 | ALIE | ASSIGNED TO LIE | — |
| Nov 15, 2007 | PARI | TEAS VOLUNTARY AMENDMENT RECEIVED | — |
| Oct 23, 2007 | NWAP | NEW APPLICATION ENTERED | — |